Global Recombinant Human Parathyroid Hormone Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Recombinant Human Parathyroid Hormone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Human Parathyroid Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Human Parathyroid Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Human Parathyroid Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Human Parathyroid Hormone players cover NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma and Beijing SL Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Recombinant Human Parathyroid Hormone Industry Forecast” looks at past sales and reviews total world Recombinant Human Parathyroid Hormone sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Human Parathyroid Hormone sales for 2023 through 2029. With Recombinant Human Parathyroid Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Parathyroid Hormone industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Parathyroid Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Parathyroid Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Human Parathyroid Hormone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Parathyroid Hormone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Parathyroid Hormone.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Parathyroid Hormone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Recombinant Human Parathyroid Hormone market?
What factors are driving Recombinant Human Parathyroid Hormone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Parathyroid Hormone market opportunities vary by end market size?
How does Recombinant Human Parathyroid Hormone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The global Recombinant Human Parathyroid Hormone market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Human Parathyroid Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Human Parathyroid Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Human Parathyroid Hormone is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Human Parathyroid Hormone players cover NPS Pharma(Shire), Takeda, Shandong Buchang Pharmaceuticals, Ascendis Pharma and Beijing SL Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Recombinant Human Parathyroid Hormone Industry Forecast” looks at past sales and reviews total world Recombinant Human Parathyroid Hormone sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Human Parathyroid Hormone sales for 2023 through 2029. With Recombinant Human Parathyroid Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Parathyroid Hormone industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Parathyroid Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Parathyroid Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Human Parathyroid Hormone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Parathyroid Hormone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Parathyroid Hormone.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Parathyroid Hormone market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 25 mcg/dose
- 50 mcg/dose
- 75 mcg/dose
- 100 mcg/dose
- Postmenopausal Women with Osteoporosis
- Hypocalcemia in Patients with Hypoparathyroidism
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NPS Pharma(Shire)
- Takeda
- Shandong Buchang Pharmaceuticals
- Ascendis Pharma
- Beijing SL Pharmaceutical
What is the 10-year outlook for the global Recombinant Human Parathyroid Hormone market?
What factors are driving Recombinant Human Parathyroid Hormone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Parathyroid Hormone market opportunities vary by end market size?
How does Recombinant Human Parathyroid Hormone break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Human Parathyroid Hormone Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Human Parathyroid Hormone by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Human Parathyroid Hormone by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Human Parathyroid Hormone Segment by Type
2.2.1 25 mcg/dose
2.2.2 50 mcg/dose
2.2.3 75 mcg/dose
2.2.4 100 mcg/dose
2.3 Recombinant Human Parathyroid Hormone Sales by Type
2.3.1 Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Human Parathyroid Hormone Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Human Parathyroid Hormone Sale Price by Type (2018-2023)
2.4 Recombinant Human Parathyroid Hormone Segment by Application
2.4.1 Postmenopausal Women with Osteoporosis
2.4.2 Hypocalcemia in Patients with Hypoparathyroidism
2.5 Recombinant Human Parathyroid Hormone Sales by Application
2.5.1 Global Recombinant Human Parathyroid Hormone Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Human Parathyroid Hormone Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Human Parathyroid Hormone Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT HUMAN PARATHYROID HORMONE BY COMPANY
3.1 Global Recombinant Human Parathyroid Hormone Breakdown Data by Company
3.1.1 Global Recombinant Human Parathyroid Hormone Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Human Parathyroid Hormone Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Human Parathyroid Hormone Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Human Parathyroid Hormone Revenue by Company (2018-2023)
3.2.2 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Human Parathyroid Hormone Sale Price by Company
3.4 Key Manufacturers Recombinant Human Parathyroid Hormone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Human Parathyroid Hormone Product Location Distribution
3.4.2 Players Recombinant Human Parathyroid Hormone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HUMAN PARATHYROID HORMONE BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Human Parathyroid Hormone Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Human Parathyroid Hormone Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Human Parathyroid Hormone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Human Parathyroid Hormone Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Human Parathyroid Hormone Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Human Parathyroid Hormone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Human Parathyroid Hormone Sales Growth
4.4 APAC Recombinant Human Parathyroid Hormone Sales Growth
4.5 Europe Recombinant Human Parathyroid Hormone Sales Growth
4.6 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Growth
5 AMERICAS
5.1 Americas Recombinant Human Parathyroid Hormone Sales by Country
5.1.1 Americas Recombinant Human Parathyroid Hormone Sales by Country (2018-2023)
5.1.2 Americas Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023)
5.2 Americas Recombinant Human Parathyroid Hormone Sales by Type
5.3 Americas Recombinant Human Parathyroid Hormone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Parathyroid Hormone Sales by Region
6.1.1 APAC Recombinant Human Parathyroid Hormone Sales by Region (2018-2023)
6.1.2 APAC Recombinant Human Parathyroid Hormone Revenue by Region (2018-2023)
6.2 APAC Recombinant Human Parathyroid Hormone Sales by Type
6.3 APAC Recombinant Human Parathyroid Hormone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Human Parathyroid Hormone by Country
7.1.1 Europe Recombinant Human Parathyroid Hormone Sales by Country (2018-2023)
7.1.2 Europe Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023)
7.2 Europe Recombinant Human Parathyroid Hormone Sales by Type
7.3 Europe Recombinant Human Parathyroid Hormone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Human Parathyroid Hormone by Country
8.1.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Type
8.3 Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Parathyroid Hormone
10.3 Manufacturing Process Analysis of Recombinant Human Parathyroid Hormone
10.4 Industry Chain Structure of Recombinant Human Parathyroid Hormone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Human Parathyroid Hormone Distributors
11.3 Recombinant Human Parathyroid Hormone Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HUMAN PARATHYROID HORMONE BY GEOGRAPHIC REGION
12.1 Global Recombinant Human Parathyroid Hormone Market Size Forecast by Region
12.1.1 Global Recombinant Human Parathyroid Hormone Forecast by Region (2024-2029)
12.1.2 Global Recombinant Human Parathyroid Hormone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Human Parathyroid Hormone Forecast by Type
12.7 Global Recombinant Human Parathyroid Hormone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 NPS Pharma(Shire)
13.1.1 NPS Pharma(Shire) Company Information
13.1.2 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 NPS Pharma(Shire) Main Business Overview
13.1.5 NPS Pharma(Shire) Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.2.3 Takeda Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Shandong Buchang Pharmaceuticals
13.3.1 Shandong Buchang Pharmaceuticals Company Information
13.3.2 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shandong Buchang Pharmaceuticals Main Business Overview
13.3.5 Shandong Buchang Pharmaceuticals Latest Developments
13.4 Ascendis Pharma
13.4.1 Ascendis Pharma Company Information
13.4.2 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ascendis Pharma Main Business Overview
13.4.5 Ascendis Pharma Latest Developments
13.5 Beijing SL Pharmaceutical
13.5.1 Beijing SL Pharmaceutical Company Information
13.5.2 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing SL Pharmaceutical Main Business Overview
13.5.5 Beijing SL Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Human Parathyroid Hormone Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Human Parathyroid Hormone by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Human Parathyroid Hormone by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Human Parathyroid Hormone Segment by Type
2.2.1 25 mcg/dose
2.2.2 50 mcg/dose
2.2.3 75 mcg/dose
2.2.4 100 mcg/dose
2.3 Recombinant Human Parathyroid Hormone Sales by Type
2.3.1 Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Human Parathyroid Hormone Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Human Parathyroid Hormone Sale Price by Type (2018-2023)
2.4 Recombinant Human Parathyroid Hormone Segment by Application
2.4.1 Postmenopausal Women with Osteoporosis
2.4.2 Hypocalcemia in Patients with Hypoparathyroidism
2.5 Recombinant Human Parathyroid Hormone Sales by Application
2.5.1 Global Recombinant Human Parathyroid Hormone Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Human Parathyroid Hormone Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Human Parathyroid Hormone Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT HUMAN PARATHYROID HORMONE BY COMPANY
3.1 Global Recombinant Human Parathyroid Hormone Breakdown Data by Company
3.1.1 Global Recombinant Human Parathyroid Hormone Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Human Parathyroid Hormone Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Human Parathyroid Hormone Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Human Parathyroid Hormone Revenue by Company (2018-2023)
3.2.2 Global Recombinant Human Parathyroid Hormone Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Human Parathyroid Hormone Sale Price by Company
3.4 Key Manufacturers Recombinant Human Parathyroid Hormone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Human Parathyroid Hormone Product Location Distribution
3.4.2 Players Recombinant Human Parathyroid Hormone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HUMAN PARATHYROID HORMONE BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Human Parathyroid Hormone Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Human Parathyroid Hormone Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Human Parathyroid Hormone Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Human Parathyroid Hormone Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Human Parathyroid Hormone Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Human Parathyroid Hormone Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Human Parathyroid Hormone Sales Growth
4.4 APAC Recombinant Human Parathyroid Hormone Sales Growth
4.5 Europe Recombinant Human Parathyroid Hormone Sales Growth
4.6 Middle East & Africa Recombinant Human Parathyroid Hormone Sales Growth
5 AMERICAS
5.1 Americas Recombinant Human Parathyroid Hormone Sales by Country
5.1.1 Americas Recombinant Human Parathyroid Hormone Sales by Country (2018-2023)
5.1.2 Americas Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023)
5.2 Americas Recombinant Human Parathyroid Hormone Sales by Type
5.3 Americas Recombinant Human Parathyroid Hormone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Parathyroid Hormone Sales by Region
6.1.1 APAC Recombinant Human Parathyroid Hormone Sales by Region (2018-2023)
6.1.2 APAC Recombinant Human Parathyroid Hormone Revenue by Region (2018-2023)
6.2 APAC Recombinant Human Parathyroid Hormone Sales by Type
6.3 APAC Recombinant Human Parathyroid Hormone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Human Parathyroid Hormone by Country
7.1.1 Europe Recombinant Human Parathyroid Hormone Sales by Country (2018-2023)
7.1.2 Europe Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023)
7.2 Europe Recombinant Human Parathyroid Hormone Sales by Type
7.3 Europe Recombinant Human Parathyroid Hormone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Human Parathyroid Hormone by Country
8.1.1 Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Type
8.3 Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Parathyroid Hormone
10.3 Manufacturing Process Analysis of Recombinant Human Parathyroid Hormone
10.4 Industry Chain Structure of Recombinant Human Parathyroid Hormone
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Human Parathyroid Hormone Distributors
11.3 Recombinant Human Parathyroid Hormone Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HUMAN PARATHYROID HORMONE BY GEOGRAPHIC REGION
12.1 Global Recombinant Human Parathyroid Hormone Market Size Forecast by Region
12.1.1 Global Recombinant Human Parathyroid Hormone Forecast by Region (2024-2029)
12.1.2 Global Recombinant Human Parathyroid Hormone Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Human Parathyroid Hormone Forecast by Type
12.7 Global Recombinant Human Parathyroid Hormone Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 NPS Pharma(Shire)
13.1.1 NPS Pharma(Shire) Company Information
13.1.2 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 NPS Pharma(Shire) Main Business Overview
13.1.5 NPS Pharma(Shire) Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.2.3 Takeda Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Shandong Buchang Pharmaceuticals
13.3.1 Shandong Buchang Pharmaceuticals Company Information
13.3.2 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shandong Buchang Pharmaceuticals Main Business Overview
13.3.5 Shandong Buchang Pharmaceuticals Latest Developments
13.4 Ascendis Pharma
13.4.1 Ascendis Pharma Company Information
13.4.2 Ascendis Pharma Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Ascendis Pharma Main Business Overview
13.4.5 Ascendis Pharma Latest Developments
13.5 Beijing SL Pharmaceutical
13.5.1 Beijing SL Pharmaceutical Company Information
13.5.2 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
13.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Beijing SL Pharmaceutical Main Business Overview
13.5.5 Beijing SL Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Human Parathyroid Hormone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Human Parathyroid Hormone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 25 mcg/dose
Table 4. Major Players of 50 mcg/dose
Table 5. Major Players of 75 mcg/dose
Table 6. Major Players of 100 mcg/dose
Table 7. Global Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 8. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Table 9. Global Recombinant Human Parathyroid Hormone Revenue by Type (2018-2023) & ($ million)
Table 10. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2018-2023)
Table 11. Global Recombinant Human Parathyroid Hormone Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 13. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Table 14. Global Recombinant Human Parathyroid Hormone Revenue by Application (2018-2023)
Table 15. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application (2018-2023)
Table 16. Global Recombinant Human Parathyroid Hormone Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Recombinant Human Parathyroid Hormone Sales by Company (2018-2023) & (K Units)
Table 18. Global Recombinant Human Parathyroid Hormone Sales Market Share by Company (2018-2023)
Table 19. Global Recombinant Human Parathyroid Hormone Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Company (2018-2023)
Table 21. Global Recombinant Human Parathyroid Hormone Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Recombinant Human Parathyroid Hormone Producing Area Distribution and Sales Area
Table 23. Players Recombinant Human Parathyroid Hormone Products Offered
Table 24. Recombinant Human Parathyroid Hormone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Recombinant Human Parathyroid Hormone Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Recombinant Human Parathyroid Hormone Sales Market Share Geographic Region (2018-2023)
Table 29. Global Recombinant Human Parathyroid Hormone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Recombinant Human Parathyroid Hormone Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Recombinant Human Parathyroid Hormone Sales Market Share by Country/Region (2018-2023)
Table 33. Global Recombinant Human Parathyroid Hormone Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Recombinant Human Parathyroid Hormone Sales by Country (2018-2023) & (K Units)
Table 36. Americas Recombinant Human Parathyroid Hormone Sales Market Share by Country (2018-2023)
Table 37. Americas Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2018-2023)
Table 39. Americas Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 40. Americas Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 41. APAC Recombinant Human Parathyroid Hormone Sales by Region (2018-2023) & (K Units)
Table 42. APAC Recombinant Human Parathyroid Hormone Sales Market Share by Region (2018-2023)
Table 43. APAC Recombinant Human Parathyroid Hormone Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Recombinant Human Parathyroid Hormone Revenue Market Share by Region (2018-2023)
Table 45. APAC Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 46. APAC Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 47. Europe Recombinant Human Parathyroid Hormone Sales by Country (2018-2023) & (K Units)
Table 48. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Country (2018-2023)
Table 49. Europe Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2018-2023)
Table 51. Europe Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 52. Europe Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Recombinant Human Parathyroid Hormone
Table 60. Key Market Challenges & Risks of Recombinant Human Parathyroid Hormone
Table 61. Key Industry Trends of Recombinant Human Parathyroid Hormone
Table 62. Recombinant Human Parathyroid Hormone Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Recombinant Human Parathyroid Hormone Distributors List
Table 65. Recombinant Human Parathyroid Hormone Customer List
Table 66. Global Recombinant Human Parathyroid Hormone Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Recombinant Human Parathyroid Hormone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Recombinant Human Parathyroid Hormone Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Recombinant Human Parathyroid Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Recombinant Human Parathyroid Hormone Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Recombinant Human Parathyroid Hormone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Recombinant Human Parathyroid Hormone Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Recombinant Human Parathyroid Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Recombinant Human Parathyroid Hormone Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Recombinant Human Parathyroid Hormone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Recombinant Human Parathyroid Hormone Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Recombinant Human Parathyroid Hormone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. NPS Pharma(Shire) Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 81. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 82. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. NPS Pharma(Shire) Main Business
Table 84. NPS Pharma(Shire) Latest Developments
Table 85. Takeda Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 86. Takeda Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 87. Takeda Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Takeda Main Business
Table 89. Takeda Latest Developments
Table 90. Shandong Buchang Pharmaceuticals Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 91. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 92. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Shandong Buchang Pharmaceuticals Main Business
Table 94. Shandong Buchang Pharmaceuticals Latest Developments
Table 95. Ascendis Pharma Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 96. Ascendis Pharma Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 97. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Ascendis Pharma Main Business
Table 99. Ascendis Pharma Latest Developments
Table 100. Beijing SL Pharmaceutical Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 101. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 102. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Beijing SL Pharmaceutical Main Business
Table 104. Beijing SL Pharmaceutical Latest Developments
Table 1. Recombinant Human Parathyroid Hormone Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Human Parathyroid Hormone Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 25 mcg/dose
Table 4. Major Players of 50 mcg/dose
Table 5. Major Players of 75 mcg/dose
Table 6. Major Players of 100 mcg/dose
Table 7. Global Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 8. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Table 9. Global Recombinant Human Parathyroid Hormone Revenue by Type (2018-2023) & ($ million)
Table 10. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2018-2023)
Table 11. Global Recombinant Human Parathyroid Hormone Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 13. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Table 14. Global Recombinant Human Parathyroid Hormone Revenue by Application (2018-2023)
Table 15. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application (2018-2023)
Table 16. Global Recombinant Human Parathyroid Hormone Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Recombinant Human Parathyroid Hormone Sales by Company (2018-2023) & (K Units)
Table 18. Global Recombinant Human Parathyroid Hormone Sales Market Share by Company (2018-2023)
Table 19. Global Recombinant Human Parathyroid Hormone Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Company (2018-2023)
Table 21. Global Recombinant Human Parathyroid Hormone Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Recombinant Human Parathyroid Hormone Producing Area Distribution and Sales Area
Table 23. Players Recombinant Human Parathyroid Hormone Products Offered
Table 24. Recombinant Human Parathyroid Hormone Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Recombinant Human Parathyroid Hormone Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Recombinant Human Parathyroid Hormone Sales Market Share Geographic Region (2018-2023)
Table 29. Global Recombinant Human Parathyroid Hormone Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Recombinant Human Parathyroid Hormone Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Recombinant Human Parathyroid Hormone Sales Market Share by Country/Region (2018-2023)
Table 33. Global Recombinant Human Parathyroid Hormone Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Recombinant Human Parathyroid Hormone Sales by Country (2018-2023) & (K Units)
Table 36. Americas Recombinant Human Parathyroid Hormone Sales Market Share by Country (2018-2023)
Table 37. Americas Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2018-2023)
Table 39. Americas Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 40. Americas Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 41. APAC Recombinant Human Parathyroid Hormone Sales by Region (2018-2023) & (K Units)
Table 42. APAC Recombinant Human Parathyroid Hormone Sales Market Share by Region (2018-2023)
Table 43. APAC Recombinant Human Parathyroid Hormone Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Recombinant Human Parathyroid Hormone Revenue Market Share by Region (2018-2023)
Table 45. APAC Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 46. APAC Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 47. Europe Recombinant Human Parathyroid Hormone Sales by Country (2018-2023) & (K Units)
Table 48. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Country (2018-2023)
Table 49. Europe Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2018-2023)
Table 51. Europe Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 52. Europe Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Recombinant Human Parathyroid Hormone Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Recombinant Human Parathyroid Hormone
Table 60. Key Market Challenges & Risks of Recombinant Human Parathyroid Hormone
Table 61. Key Industry Trends of Recombinant Human Parathyroid Hormone
Table 62. Recombinant Human Parathyroid Hormone Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Recombinant Human Parathyroid Hormone Distributors List
Table 65. Recombinant Human Parathyroid Hormone Customer List
Table 66. Global Recombinant Human Parathyroid Hormone Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Recombinant Human Parathyroid Hormone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Recombinant Human Parathyroid Hormone Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Recombinant Human Parathyroid Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Recombinant Human Parathyroid Hormone Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Recombinant Human Parathyroid Hormone Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Recombinant Human Parathyroid Hormone Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Recombinant Human Parathyroid Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Recombinant Human Parathyroid Hormone Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Recombinant Human Parathyroid Hormone Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Recombinant Human Parathyroid Hormone Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Recombinant Human Parathyroid Hormone Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. NPS Pharma(Shire) Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 81. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 82. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. NPS Pharma(Shire) Main Business
Table 84. NPS Pharma(Shire) Latest Developments
Table 85. Takeda Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 86. Takeda Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 87. Takeda Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Takeda Main Business
Table 89. Takeda Latest Developments
Table 90. Shandong Buchang Pharmaceuticals Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 91. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 92. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Shandong Buchang Pharmaceuticals Main Business
Table 94. Shandong Buchang Pharmaceuticals Latest Developments
Table 95. Ascendis Pharma Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 96. Ascendis Pharma Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 97. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Ascendis Pharma Main Business
Table 99. Ascendis Pharma Latest Developments
Table 100. Beijing SL Pharmaceutical Basic Information, Recombinant Human Parathyroid Hormone Manufacturing Base, Sales Area and Its Competitors
Table 101. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Portfolios and Specifications
Table 102. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Beijing SL Pharmaceutical Main Business
Table 104. Beijing SL Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Human Parathyroid Hormone
Figure 2. Recombinant Human Parathyroid Hormone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Parathyroid Hormone Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Recombinant Human Parathyroid Hormone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Human Parathyroid Hormone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 25 mcg/dose
Figure 10. Product Picture of 50 mcg/dose
Figure 11. Product Picture of 75 mcg/dose
Figure 12. Product Picture of 100 mcg/dose
Figure 13. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type in 2022
Figure 14. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2018-2023)
Figure 15. Recombinant Human Parathyroid Hormone Consumed in Postmenopausal Women with Osteoporosis
Figure 16. Global Recombinant Human Parathyroid Hormone Market: Postmenopausal Women with Osteoporosis (2018-2023) & (K Units)
Figure 17. Recombinant Human Parathyroid Hormone Consumed in Hypocalcemia in Patients with Hypoparathyroidism
Figure 18. Global Recombinant Human Parathyroid Hormone Market: Hypocalcemia in Patients with Hypoparathyroidism (2018-2023) & (K Units)
Figure 19. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2022)
Figure 20. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application in 2022
Figure 21. Recombinant Human Parathyroid Hormone Sales Market by Company in 2022 (K Units)
Figure 22. Global Recombinant Human Parathyroid Hormone Sales Market Share by Company in 2022
Figure 23. Recombinant Human Parathyroid Hormone Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Company in 2022
Figure 25. Global Recombinant Human Parathyroid Hormone Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Recombinant Human Parathyroid Hormone Sales 2018-2023 (K Units)
Figure 28. Americas Recombinant Human Parathyroid Hormone Revenue 2018-2023 ($ Millions)
Figure 29. APAC Recombinant Human Parathyroid Hormone Sales 2018-2023 (K Units)
Figure 30. APAC Recombinant Human Parathyroid Hormone Revenue 2018-2023 ($ Millions)
Figure 31. Europe Recombinant Human Parathyroid Hormone Sales 2018-2023 (K Units)
Figure 32. Europe Recombinant Human Parathyroid Hormone Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Recombinant Human Parathyroid Hormone Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue 2018-2023 ($ Millions)
Figure 35. Americas Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2022
Figure 36. Americas Recombinant Human Parathyroid Hormone Revenue Market Share by Country in 2022
Figure 37. Americas Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Figure 38. Americas Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Figure 39. United States Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Recombinant Human Parathyroid Hormone Sales Market Share by Region in 2022
Figure 44. APAC Recombinant Human Parathyroid Hormone Revenue Market Share by Regions in 2022
Figure 45. APAC Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Figure 46. APAC Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Figure 47. China Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2022
Figure 55. Europe Recombinant Human Parathyroid Hormone Revenue Market Share by Country in 2022
Figure 56. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Figure 57. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Figure 58. Germany Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Figure 67. Egypt Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Human Parathyroid Hormone in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Human Parathyroid Hormone
Figure 74. Industry Chain Structure of Recombinant Human Parathyroid Hormone
Figure 75. Channels of Distribution
Figure 76. Global Recombinant Human Parathyroid Hormone Sales Market Forecast by Region (2024-2029)
Figure 77. Global Recombinant Human Parathyroid Hormone Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Human Parathyroid Hormone Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Recombinant Human Parathyroid Hormone Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Recombinant Human Parathyroid Hormone
Figure 2. Recombinant Human Parathyroid Hormone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Parathyroid Hormone Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Recombinant Human Parathyroid Hormone Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Human Parathyroid Hormone Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 25 mcg/dose
Figure 10. Product Picture of 50 mcg/dose
Figure 11. Product Picture of 75 mcg/dose
Figure 12. Product Picture of 100 mcg/dose
Figure 13. Global Recombinant Human Parathyroid Hormone Sales Market Share by Type in 2022
Figure 14. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Type (2018-2023)
Figure 15. Recombinant Human Parathyroid Hormone Consumed in Postmenopausal Women with Osteoporosis
Figure 16. Global Recombinant Human Parathyroid Hormone Market: Postmenopausal Women with Osteoporosis (2018-2023) & (K Units)
Figure 17. Recombinant Human Parathyroid Hormone Consumed in Hypocalcemia in Patients with Hypoparathyroidism
Figure 18. Global Recombinant Human Parathyroid Hormone Market: Hypocalcemia in Patients with Hypoparathyroidism (2018-2023) & (K Units)
Figure 19. Global Recombinant Human Parathyroid Hormone Sales Market Share by Application (2022)
Figure 20. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Application in 2022
Figure 21. Recombinant Human Parathyroid Hormone Sales Market by Company in 2022 (K Units)
Figure 22. Global Recombinant Human Parathyroid Hormone Sales Market Share by Company in 2022
Figure 23. Recombinant Human Parathyroid Hormone Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Company in 2022
Figure 25. Global Recombinant Human Parathyroid Hormone Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Recombinant Human Parathyroid Hormone Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Recombinant Human Parathyroid Hormone Sales 2018-2023 (K Units)
Figure 28. Americas Recombinant Human Parathyroid Hormone Revenue 2018-2023 ($ Millions)
Figure 29. APAC Recombinant Human Parathyroid Hormone Sales 2018-2023 (K Units)
Figure 30. APAC Recombinant Human Parathyroid Hormone Revenue 2018-2023 ($ Millions)
Figure 31. Europe Recombinant Human Parathyroid Hormone Sales 2018-2023 (K Units)
Figure 32. Europe Recombinant Human Parathyroid Hormone Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Recombinant Human Parathyroid Hormone Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue 2018-2023 ($ Millions)
Figure 35. Americas Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2022
Figure 36. Americas Recombinant Human Parathyroid Hormone Revenue Market Share by Country in 2022
Figure 37. Americas Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Figure 38. Americas Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Figure 39. United States Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Recombinant Human Parathyroid Hormone Sales Market Share by Region in 2022
Figure 44. APAC Recombinant Human Parathyroid Hormone Revenue Market Share by Regions in 2022
Figure 45. APAC Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Figure 46. APAC Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Figure 47. China Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2022
Figure 55. Europe Recombinant Human Parathyroid Hormone Revenue Market Share by Country in 2022
Figure 56. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Figure 57. Europe Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Figure 58. Germany Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Human Parathyroid Hormone Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Recombinant Human Parathyroid Hormone Sales Market Share by Application (2018-2023)
Figure 67. Egypt Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Recombinant Human Parathyroid Hormone Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Human Parathyroid Hormone in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Human Parathyroid Hormone
Figure 74. Industry Chain Structure of Recombinant Human Parathyroid Hormone
Figure 75. Channels of Distribution
Figure 76. Global Recombinant Human Parathyroid Hormone Sales Market Forecast by Region (2024-2029)
Figure 77. Global Recombinant Human Parathyroid Hormone Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Human Parathyroid Hormone Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Recombinant Human Parathyroid Hormone Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Recombinant Human Parathyroid Hormone Revenue Market Share Forecast by Application (2024-2029)
